The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 04, 2022
Filed:
Nov. 18, 2016
Applicant:
Denali Therapeutics Inc., South San Francisco, CA (US);
Inventors:
Anthony A. Estrada, San Mateo, CA (US);
Jianwen A. Feng, San Mateo, CA (US);
Joseph P. Lyssikatos, South San Francisco, CA (US);
Zachary K. Sweeney, Redwood City, CA (US);
Javier de Vicente Fidalgo, Foster City, CA (US);
Assignee:
DENALI THERAPEUTICS INC., South San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 487/04 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01); A61K 31/4439 (2006.01); C07D 413/14 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract
Compounds having activity as LRRK2 inhibitors are disclosed. The compounds are of formula (I) including stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds are also disclosed.